ArticleFrontiers in medicine2021

FABP5, a Novel Immune-Related mRNA Prognostic Marker and a Target of Immunotherapy for Multiple Myeloma.

Haipeng Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.